Highest Certainty for Cash Flow of Any LP
    • Written and edited by Capital Ideas Media Team

     

    The Hydropothecary (TSX:HEXO) PI Financial has started coverage with a “buy” rating and a price target of $8.50 (Canadian), implying nearly 70% upside, saying the company’s backlog of about $900 million with the Quebec government gives the company the “highest certainty on future cash flows from any licensed producer currently in the industry”.